Replies to post #401968 on Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Excellent. So new and improved fiber technology for hard to treat malady's using their StingRay systems.

[steelyeye]

This is significant... I didn't realize IPIX owns approx. 42% of the laser company, BeaMed Technologies, LTD.
BeaMed could be acquired by any number of pharmas, which would automatically give a boost to IPIX share price.

And the FDA has given BeaMed clearance to market their device:
https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232769.pdf

The number of surgical applications where the BeaMed StingRay laser can be utilized with superior advantages, including conforming the laser to the shape of the target without consequential damage to surrounding tissue will be a welcome and much needed improvement in many surgical applications. A large distribution network for the laser is already in place. IPIX owns approximately 42% of BeaMed Technologies, LTD. As a substantial investor, I could not be more excited at this pivitol point in time. You can learn more about it here: https://www.beam-med.com/

"The BeaMed Laser Surgery Fibers have a wavelength range of 450 nm to 2100 nm, can be
used in contact and non-contact mode and are indicated for use in general surgery, urology,
gastroenterology, gynecology, dermatology, vascular surgery, neurosurgery, plastic surgery,
ENT and endovenous occlusion of the greater saphenous vein in the patient with superficial
vein reflux and laser assisted lipolysis with a cleared compatible laser marketed for the
mentioned intended uses and using an SMA 905 connector."